Right now we don’t have enough vaccines. But in a few months, when we have a larger supply, few people may be ready to take the vaccines we have.
All leaders have stressed that they are looking for ways to increase production to meet the overwhelming demand for the largest global vaccination campaign in history.
“We understand the tremendous interest in Moderna’s vaccine, as well as vaccine candidates and vaccine candidates from other companies,” said Moderna President Stephen Hoge. “We also understand how important it is that large quantities of every approved vaccine are produced quickly … and that vaccines are made available widely, in a transparent and equitable manner.”
President Joe Biden has pledged to deliver 100 million doses in his first 100 days, a goal that advisers say is achievable by administering more than a million doses per day – a level the country has already outdated. The administration should aim even higher, Republican Cathy McMorris Rodgers, ranked on the energy and commerce rankings, called on the White House to shoot for two million every day.
Biden has also said on several occasions that all Americans who want to be vaccinated should be able to do so by July.
Vaccine makers have also discussed the growing threat from different strains of coronavirus such as B.1.315, the variant first found in South Africa and which appears to be less sensitive to certain vaccines.
Moderna is starting trials with the National Institutes of Health for a booster shot targeting this strain. Pfizer is in talks with the FDA about designing clinical studies to test updated versions of its own vaccine against emerging variants, said chief commercial officer John Young.
Novavax, which just completed trial registration in the United States this week for its large Phase III trial, “is already actively working on a strategy to provide the broadest coverage,” said John Trizzino, director. commercial and commercial director. He added that the company’s technology and manufacturing process make it easy to modify and scale up modified vaccines.